Skip to content

Author

Jia-Wei Geng

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.

BACKGROUND Simedeutirom is a selective thyroid hormone receptor-β agonist that has previously been shown to reduce hepatic fat content in metabolic dysfunction-associated steatotic liver disease. We assessed the efficacy and safety of simedeutirom in patients of Asian descent with biopsy-confirmed metabolic dysfunction...

Feng Xue, Jian-Feng Liu, Jin-jun Chen et al. · 1 citation
Open access Sep 2026

Genomic and functional characterization of six novel phages targeting multidrug-resistant Escherichia coli: promising candidates for clinical phage therapy

Six novel lytic bacteriophages from hospital wastewater that specifically infect MDR E. coli clinical isolates exhibited strictly lytic lifestyles, and genomic analysis confirmed the absence of lysogeny, virulence, or antibiotic-resistance genes, making them promising candidates for phage cocktail therapy.

Ling-Ling Xiong, Xiao-Lian Shen, Ying-Ying Xiang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.